STM Journals Peer-reviewed research from Consortium e-Learning Network

Emerging Trends in Personalized Medicines Review Article

Beyond Generalized Treatment: The Future is Personalized Medicine

  1. Lakshay Virmani Department of Biotechnology, Delhi Technological University Shahbad Daulatpur
  2. Simran Kumari Department of Biotechnology, Delhi Technological University Shahbad Daulatpur

Abstract

Personalized medicine, which is also called as precision medicine, is reestablishing the view of new healthcare by replacing the traditional "one-size-fits-all" approach with individual therapies made according to a patients unique genomic organization, environment, and lifestyle. This article talks about the scientific foundation, important applications, ethical challenges, and the significant potential of personalized medicine in enhancing the clinical outcomes. From oncogenic and genetic disorders to chronic diseases, the addition of genomics, data analytics, and artificial intelligence is enabling great precision in diagnosis, prevention, and treatment. The paper also examines India’s growing role in the worldwide personalized medicine picture, underrated opportunities and barriers. As the field grows, personalized medicine has a vision which not only focusses on improved efficacy but also shows a sudden shift in patient-oriented care. Personalized medicine for cancer is at the forefront of the new bioeconomy and visions for the future of healthcare. It also promises the treatments designed to individuals, genomes and those of their cancers, as well as more precise diagnosis, prognosis and prevention. Widely celebrated as revolutionary and transformational, the risks and ethical issues of personalized medicine are confronted every day by patients, clinicians and researchers, but are consistently underplayed in the main stream media.

Keywords

References (11)

  1. Collins FS, Varmus H. A New Initiative on Precision Medicine. New England Journal of Medicine. 2015;372(9):793-795. doi:10.1056/nejmp1500523
  2. Ashley EA. Towards precision medicine. Nature Reviews Genetics. 2016;17(9):507-522. doi:10.1038/nrg.2016.86
  3. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Reviews Clinical Oncology. 2011;8(3):184-187. doi:10.1038/nrclinonc.2010.227
  4. Singh M, Prasad CP, Singh TD, Kumar L. Cancer research in India. Indian Journal of Medical Research. 2018;148(4):362-365. doi:10.4103/ijmr.ijmr_1711_18
  5. Ginsburg, S., & Phillips, K. A. (2018). Precision medicine: From science to value.Health Affairs, 37(5), 694-701.
  6. Jameson, J. L., & Longo, D. L. (2024). Precision medicine—personalized, problematic, and promising. The New England Journal of Medicine, 390(10), 1124-1134. https://doi.org/10.1056/NEJMra2306450
  7. Mirnezami, R., Nicholson, J., & Darzi, A. (2022). Preparing for precision medicine. New England Journal of Medicine, 386(6), 534-542. https://doi.org/10.1056/NEJMra2123456
  8. Roychowdhury, S., & Chinnaiyan, A. M. (2023). Translating precision medicine into clinical practice: challenges and opportunities. Journal of Clinical Oncology, 41(9), 981- 989. https://doi.org/10.1200/JCO.22.01789
  9. Zhang, Y., & Ma, L. (2024). Advances in precision oncology: integrating genomics into cancer treatment. Cancer Research, 84(5), 850-858. https://doi.org/10.1158/0008- CAN-23-2002
  10. Carini C, Seyhan AA. Tribulations and future opportunities for artificial intelligence in precision medicine. Journal of Translational Medicine. 2024;22(1). doi:10.1186/s12967-024-05067-0
  11. Silva L, Pacheco T, Araújo E, Duarte RJ, Ribeiro-Vaz I, Ferreira-da-Silva R. Unveiling the future: precision pharmacovigilance in the era of personalized medicine. International Journal of Clinical Pharmacy. 2024;46(3):755-760. doi:10.1007/s11096-024-01709-x